Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from

Chenxu Yu1, Jacob Hale, Kenneth Ritchie

  • 1Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, IN, USA.

Insights

Cancer cells respond differently to Epidermal Growth Factor (EGF) based on Epidermal Growth Factor Receptor (EGFR) levels. Single-molecule imaging reveals distinct binding kinetics and dimer formation, impacting cell signaling pathways.

Area of Science:

  • Cell Biology
  • Biophysics
  • Cancer Research

Background:

  • Epidermal Growth Factor Receptor (EGFR) is a key target in cancer therapy.
  • Understanding Epidermal Growth Factor (EGF) binding kinetics is crucial for cancer treatment strategies.
  • Cancer cells exhibit varying EGFR expression levels, influencing cellular response.

Purpose of the Study:

  • To investigate the single-molecule binding kinetics of EGF to EGFR in cancer cells with different EGFR expression levels.
  • To elucidate how EGFR density affects EGF-EGFR interactions and dimer formation.
  • To assess the impact of EGFR inhibition on binding dynamics.

Main Methods:

  • Utilized Total Internal Reflectance Fluorescence (TIRF) microscopy for single-molecule precision.
  • Employed mathematical modeling to analyze binding kinetics.
  • Studied EGF-EGFR interactions in HeLa and MDA-MB-468 cancer cell lines.
  • Investigated the effect of the EGFR inhibitor AG1478.

Main Results:

  • Cells with higher EGFR expression (MDA-MB-468) showed more pre-formed dimers and enhanced EGF binding at lower concentrations compared to HeLa cells.
  • A shorter time-lapse between sequential EGF binding to dimers was observed in high-EGFR cells.
  • EGFR inhibition with AG1478 significantly increased the formation of pre-formed EGFR dimers.

Conclusions:

  • EGFR expression levels critically modulate EGF-EGFR binding kinetics and dimer formation in cancer cells.
  • Single-molecule analysis provides novel quantitative insights into cancer cell signaling mechanisms.
  • Surface binding kinetics may serve as predictive biomarkers for signaling pathway outcomes.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.